Baxter International Inc. has launched the Welch Allyn Connex 360 Vital Signs Monitor, its next- generation patient monitoring device that offers an advanced connectivity and security platform, customizable configurations based on a hospital’s clinical routines, and upgrade capabilities that set the stage for future functionality and enhancements. With automated clinical documentation, Connex 360 is designed to simplify the clinician experience and allow more time to focus on patients, according to the company.

“There is nothing more important than keeping patients safe, especially when time is of the essence,” Baxter Front Line Care President Julie Foster said. “Care teams rely on vital signs monitoring to help detect changes in their patients’ conditions and make informed decisions. With Connex 360, we are advancing patient monitoring to provide care teams with the timely insights they need at the bedside, so they can make the most of every moment with their patients.”

The current healthcare environment requires care teams and hospital staff to accomplish more with less, and timely, accurate, secure patient information is critical. Baxter’s Connex 360 monitor captures vital signs for adult, pediatric and neonate patients, including blood pressure, temperature, pulse rate, respiration rate¹ and blood oxygen levels.² Designed for optimized workflows, care teams can obtain a full set of patient vitals in less than one minute and automatically send to the electronic medical record, thereby helping reduce manual data entry errors and support informed care decisions.

This secure data flow is powered by Baxter’s cloud-based DeviceBridge platform, which works behind the scenes to help enable accurate data transfer from Connex 360 to hospital IT systems, including the EMR. DeviceBridge also helps support secure device access and clinical data interoperability across Baxter’s ecosystem of connected devices.

Additional key features of Connex 360 include:

• Comprehensive security: Enhanced security features, including end-to-end encryption and certificate-based authentication, help protect patient and facility information.
• Intuitive interface: Baxter’s largest and most responsive color touchscreen allows intuitive navigation and the ability to see more patient data on one screen.
• Enhanced customization: Customizable Early Warning Score protocols alert clinicians to patient deterioration or changes in condition, and fully configurable monitoring modes support the individual needs of the patient.
• Easy upgrades and maintenance: Software upgrades for clinical, operational, and cybersecurity enhancements are streamlined, helping to reduce the burden on hospital IT teams and allowing for enhanced functionality over time.

Baxter expanded its presence in the patient monitoring space through its acquisition of Hillrom and the Welch Allyn portfolio. Baxter has continued to invest in connected monitoring, with Connex 360 joining the company’s lineup of vital signs solutions. The Connex 360 monitor is cleared by the U.S. Food and Drug Administration. 

Baxter has developed a portfolio of connected solutions, medical devices, and advanced injectable technologies. Approximately 38,000 Baxter team members live the company’s enduring mission—to save and sustain Lives.

References
¹ Digitally measure respiration rate with Masimo RRp, for patients greater than two years old.
² For a system configured with the Masimo SpO2 module and the SpO2 sensor RRp measurement option, the noninvasive measurement of Respiration Rate is not intended to be used for neonatal/infant patients.